14159, L.P.
CIK 0001551138 Name as filed on the most recent filing
Filed as 14159, L.P. (91)
1,094 transaction lines · from 91 filings · filed 2012-07-13 to 2019-04-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Genomic Health Inc 47 filings
- ISSUER Acadia Pharmaceuticals Inc 9 filings
- ISSUER Idera Pharmaceuticals, Inc. 3 filings
- ISSUER Incyte Corp 5 filings
- ISSUER BeiGene, Ltd. 3 filings
- ISSUER Xoma Corp 9 filings
- ISSUER Seattle Genetics Inc /WA 10 filings
- ISSUER Synageva Biopharma Corp 4 filings
- ISSUER Biocryst Pharmaceuticals Inc 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 9,232 disposed | 65.32 | 603,070.24 | Form 4, filing 0001638599-19-000430 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,417 disposed | 65.32 | 92,563.97 | Form 4, filing 0001638599-19-000430 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 244 disposed | 65.32 | 15,939.03 | Form 4, filing 0001638599-19-000430 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 158 disposed | 65.32 | 10,321.18 | Form 4, filing 0001638599-19-000430 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 142 disposed | 65.32 | 9,275.99 | Form 4, filing 0001638599-19-000430 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 11 disposed | 65.32 | 718.56 | Form 4, filing 0001638599-19-000430 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 173,085 disposed | 64.62 | 11,184,700.77 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 63,775 disposed | 67.13 | 4,281,177.48 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 26,575 disposed | 64.62 | 1,717,268.53 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 9,791 disposed | 67.13 | 657,263.96 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 4,581 disposed | 64.62 | 296,022.85 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 2,966 disposed | 64.62 | 191,662.03 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 2,656 disposed | 64.62 | 171,629.92 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,688 disposed | 67.13 | 113,314.43 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,093 disposed | 67.13 | 73,372.43 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 979 disposed | 67.13 | 65,719.68 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 202 disposed | 64.62 | 13,053.18 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-12 |
Genomic Health Inc GHDX |
S, Open-market sale | 74 disposed | 67.13 | 4,967.58 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 106,054 disposed | 66.61 | 7,063,981.20 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 60,618 disposed | 67.42 | 4,086,914.05 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 16,282 disposed | 66.61 | 1,084,501.69 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 9,307 disposed | 67.42 | 627,485.39 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 2,807 disposed | 66.61 | 186,966.97 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,817 disposed | 66.61 | 121,025.65 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,628 disposed | 66.61 | 108,436.85 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,604 disposed | 67.42 | 108,142.96 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,039 disposed | 67.42 | 70,050.21 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 930 disposed | 67.42 | 62,701.34 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 124 disposed | 66.61 | 8,259.32 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-11 |
Genomic Health Inc GHDX |
S, Open-market sale | 71 disposed | 67.42 | 4,786.88 | Form 4, filing 0001638599-19-000429 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 10,832 disposed | 69.12 | 748,734.92 | Form 4, filing 0001638599-19-000428 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,663 disposed | 69.12 | 114,950.72 | Form 4, filing 0001638599-19-000428 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 287 disposed | 69.12 | 19,838.16 | Form 4, filing 0001638599-19-000428 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 185 disposed | 69.12 | 12,787.66 | Form 4, filing 0001638599-19-000428 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 166 disposed | 69.12 | 11,474.34 | Form 4, filing 0001638599-19-000428 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 13 disposed | 69.12 | 898.59 | Form 4, filing 0001638599-19-000428 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 102,618 disposed | 68.70 | 7,049,918.17 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 15,755 disposed | 68.70 | 1,082,377.95 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 2,716 disposed | 68.70 | 186,590.83 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,758 disposed | 68.70 | 120,775.65 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,575 disposed | 68.70 | 108,203.44 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-10 |
Genomic Health Inc GHDX |
S, Open-market sale | 120 disposed | 68.70 | 8,244.07 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-09 |
Genomic Health Inc GHDX |
S, Open-market sale | 15,543 disposed | 67.68 | 1,051,888.07 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-09 |
Genomic Health Inc GHDX |
S, Open-market sale | 2,386 disposed | 67.68 | 161,474.94 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-09 |
Genomic Health Inc GHDX |
S, Open-market sale | 1,813 disposed | 67.87 | 123,046.86 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-09 |
Genomic Health Inc GHDX |
S, Open-market sale | 411 disposed | 67.68 | 27,814.84 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-09 |
Genomic Health Inc GHDX |
S, Open-market sale | 278 disposed | 67.87 | 18,867.64 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-09 |
Genomic Health Inc GHDX |
S, Open-market sale | 266 disposed | 67.68 | 18,001.82 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-09 |
Genomic Health Inc GHDX |
S, Open-market sale | 239 disposed | 67.68 | 16,174.56 | Form 4, filing 0001638599-19-000427 | |
| 2019-04-09 |
Genomic Health Inc GHDX |
S, Open-market sale | 48 disposed | 67.87 | 3,257.72 | Form 4, filing 0001638599-19-000427 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. 14159, L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001551138
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6